Skip to content

The Bluebelle Study: complex, simple and absent wound dressings in elective surgery: Phase A

The Bluebelle Study: a feasibility study of complex, simple and absent wound dressings in elective surgery: Phase A

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN06792113
Enrollment
170
Registered
2014-03-20
Start date
2014-06-26
Completion date
Unknown
Last updated
2019-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound infection Surgery

Interventions

This is non-interventional study. All interviews will take between 30-45 minutes and there is no planned follow up. Interviews to explore participant perspectives on wound dressing will include questi

Sponsors

University Hospitals Bristol NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adult patients aged 18 or over undergoing elective abdominal surgery, including, but not limited to, gastrectomy for benign and malignant disease, cholecystectomy, small or large bowel resection for benign or malignant conditions, abdominal wall hernia surgery (inguinal, femoral, incisional, epigastric and paraumbilical) or elective obstetric surgery (caesarean section) 2. Consultant surgeons, senior trainees, qualified nurses and midwives involved in the care and management of patients undergoing elective abdominal, obstetric or paediatric surgery Added 24/11/2014: An amendment has been approved (18/11/2014) to allow the inclusion of emergency abdominal surgery and emergency caesarean patients who have had an infection.

Exclusion criteria

Exclusion criteria: 1. Paediatric patients 2. Patients unable to give written consent 3. Patients undergoing types of surgery other than abdominal and obstetric surgery 4. Patients having emergency surgery 5. Staff who do not work in field of abdominal, paediatric or obstetric surgery

Design outcomes

Primary

MeasureTime frame
To establish patient and staff views about wound dressings

Secondary

MeasureTime frame
To develop two comprehensive measures of Surgical Site Infection (one for observer completion and the second for patient-reported outcomes) that will be validated in a future pilot randomised controlled trial

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 20, 2026